Worldwide Operation

JPI operates in more than 11 countries to ensure a global level of performance that is sought after and recognized as a once growing organization, that has become a leader and a key player in those markets.
In tribute to JPI’s adherence to the international standards of manufacturing, JPI has recently been awarded the European Good Manufacturing Practice Certificate, in addition to EMEA approval. It has also become the first and only Saudi drug manufacturing company to obtain the American Food and Drug Administration (FDA) approval to sell some of its products in the United States. Today, JPI has registered its production lines in all countries at which it operates.